Advances in neovascular macular degeneration, as presented at the American Society of Retina Specialists (ASRS) 2025 annual meeting, include data on efficacy and dosing intervals for aflibercept 8 mg ...

LOS ANGELES — Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

A new technique reported in the February 2015 issue of The FASEB Journal suggests that during early stages, it might be possible to reverse age-related macular degeneration, a leading cause of ...

In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 and older. It affects the central portion of the retina, called the macula.

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead ...

A large retinal imaging study suggests a common diabetes drug may help slow progression toward sight-threatening macular degeneration, though clinical trials are still needed to confirm any protective ...

EyePoint said on Thursday an independent safety committee found no new concerns in ​two late-stage trials of its experimental eye disease drug ‌Duravyu and recommended the studies continue unchanged.

Macular degeneration and macular dystrophy are eye conditions affecting the center of the retina. Although they share overlapping symptoms, their root causes and treatments differ. Macular ...

Share on Pinterest A commonly prescribed diabetes medication is emerging as a promising treatment for age-related macular degeneration (AMD). George Pachantouris/Getty Images Researchers say the type ...